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interassay(between-run)precisionprofilesfrom results from 101 laboratories, whichused the five mostpopular kits in the survey;duringthe controlperiod (one year) each laboratory assayed 4 EQA pools distributed (as hidden replicates) in five occasions. The interassay CV was relatively low (9-i 3%) for three poolsin the normal TSH range (>0.8 milli-int. unitlL) but markedly higher (30-40%, except for one more precise kit) in the subnormal range (0.2 milli-int. unit/L). We calculated the effect of the between-run variability on the diagnostic accuracy (discrimination between normal and subnormal values) for three representative TSH concentrations: 0.2,0.4, and 0.5 milli-int. unit/L (0.3 milli-int. unit/L was considered the lower normal limit). The three concentrations were reasonably discriminated (P s5%), and only one kit showed a between-run CV <i8% at 0.2 milli-int. unitlL. For the other four less-precise kits, only the higher TSH value (0.5 miili-int. unit/L) could be classified with an acceptable diagnostic reliability. With the most precise kit, one can distinguishtwo TSH concentrations in the 0.3-0.5 milli-int. unit/L range that differ by at least 30%; with the other kits, differences greater than 50-60% are needed for reliable discrimination. Thus many laboratories fall to achieve the functional sensitivity of a second-generation assay, even if they use immunomettic methods. TSH assays with a better interassay precision in the low concentration range are needed. Figure 2) 1 that lies beyond the lower limit of the normal range (assumed as 0.3 milli-int. unitfL). Conversely, we obtained the rate of false positives from the tail of the distribution for a normal value that falls below the lower limit of the normal range. The percentage of false results (either false negatives or false positives) was read on the table of the standard normal distribution (z score); the z-score value was computed as z = (lower limit -x)ISD, where x is the chosen TSH when the number of false results is <5%.
Following the same statistical approach, we used the between-run precision profile to estimate the ability to discriminate between two TSH values in the low concentration range. After a value x was assigned, the nearest y value (y <x) distinguishable from x was determined by setting the z score, z = (x -y)/(SD2 + SD2)#{176}5, equal to 1.65 . In other words, we ensured that the difference (x -y) significantly differed from 0 at P <0.05. These computations were carried out for three arbitrarily assigned TSH values (0.3,0.4, and 0.5 milli-int. unitlL) and for the five kits considered.
Results
The overall means of the determinations The overall agreement (or total CV) of the results in the normal TSH range was relatively good in all cases (28.3% for P042, 27.6% for P049, 18.6% for P050), but was markedly worse for the low-concentration poo1 P048 (45.6%). Figure 1 shows the histogram of all data collected for the pool P048. Despite some right-sided skewness, the distribution could be reasonably regarded as symmetrical around the mean (0.22 milli-int. unitfL). However, the spread of the data is so large that a consistent fraction of both clearly subnormal and normal values have been reported by participants for the same control material.
This large spread cannot be attributed to systematic differences between the means of different kits, as demonstrated by the relevant data shown in Table 1 (Figure 2) indicate that, for the pool at higher TSH concentration (P050), the total variability (CV 18.6%) is -70% attributable to the within-kit component, with the remaining 30% being due to systematic between-kit differences; on the other hand, for the low-concentration pool P048, the within-kit component accounts for as much as 95% of the total variability of the data.
Clearly, total variability is enlarged to some extent by the fact that results are produced in different laboratories that use different kits. For this reason, we evaluated the variability of single laboratories to estimate whether their within-laboratory interassay precision was adequate to allow the discrimination of TSH subnormal values from euthyroidism. Table 1 shows the median and range of the interassay precision obtained for the four EQA pools by the laboratories that used the kit considered. These data are also presented in the interassay precision profiles depicted in Figure 3 , proifies that can be considered as representative of the analytical performance of the different kits in the hands of the average-quality laboratory.
For the kits from Serono Maiaclone (ARS), Boehringer Enzymun (BHN), Abbott (IMX), and BykSangtec (MAT), the interassay variability of the lowconcentration pool (0.22 milli-int. unitfL) was very high (CV = 30-40%), implying that many users of these kits fail to achieve a "second-generation" functional performance; in particular, only 20-25% of the laboratories that used ARS, IMX, and MAT kits (but none of the BHN users) exhibited a second-generation performance. On the other hand, the Behring immunoradiometric assay (BEH) showed a CV of 17.6% for the low pool, and 75% of the users of this kit achieved a functional sensitivity better than 0.2 milli-int. unitlL. The precision at higher concentrations (>0.8 milli-int. unitlL) was relatively good (9-13%, on average) and adequate for all five kits.
The effect of the interassay precision on the diagnostic accuracy (discrimination between normal and subnormal values) was calculated by assuming 0.3 milli-int. unitlL as the lower normal limit. The diagnostic accuracy of the average-quality laboratory is reported in Table 2 The effect of the interassay variability on the minimum TSH decrease that can be significantly detected was evaluated at three assigned concentrations (0.3,0.4, and 0.5 milli-int. unitlL) for each of the five kits. This discrimination is typically requested in monitoring patients receiving suppressive therapy with thyroxin. With the kit that had the best between-run precision (BEH), we could distinguish two TSH concentrations in the range 0.3-05 milli-int. unitiL, if they differed by at least 30%; with the other, less precise, kits, differences of 50-60% or more were needed.
DiscussIon
The use of the within-run precision profile and of the detection limit (both estimated from within-run repli- 
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The Interassay vanabllity is the median of the interassay CVsobtainedby the laboratories; the range of CVs is also reported. between.run CV. For kit codes, see footnote to Table 1 cates) to evaluate a kit's analytical performance involves some risk of extrapolating to overall routine operation a judgment derived from a merely episodic observation. To prevent this risk, several investigators have proposed and adopted the use of between-run assessment (1-3, 12) . This approach to the analysis of (Table 2) , despite the large differences indicated by kit manufacturers for the lower normal limit (0.10-0.43 milli-int. unitfL). Changing the cutoff value, however, although modifying the rates of false positive and false negative results, affects only niinim11y the overall width of the indeterminate zone. The lack of discrimination observed for these kits does not affect the classification of overt hyperthyroidism, for which the immunometric assays were developed. Instead, their still insufficient between-run precision makes it difficult to distinguish among two TSH measurements in the lower range and hence to evaluate over time the effects of thyroid-hormone therapy (13). These conclusions obviously refer to the laboratory of average quality, with the understanding that betterperforming laboratories can fully discriminate, even when using less-precise kits, and that some users of the more precise kits cannot achieve these diagnostic goals. In any case, our findings depict a much more pessimistic situation than that emerging from the sensitivity and precision data provided with kit instructions and based on the most favorable experimental conditions. Moreover, our conclusions on the clinical performances of the kits take into account only the between-run variability estimated from replicates of control materials; other factors, e.g., the presence of interfering substances in patients' samples, can further deteriorate diagnostic accuracy.
A new class of kits, having enhanced precision at lower concentrations-either from greater sensitivity or from improved stability over time of the reagents and experimental conditions-should be developed to replace the second-generation methods currently used in the laboratory. The first third-generation TSH immunoassay with a functional sensitivity of about 0.02 milli-int. unitlL (10-fold greater than that of the secondgeneration IMAs) has been recently described (12-14) and appears to be a promising tool to refine the assessment of the thyroid status.
